Restoring Gut Metabolites in Multiple Sclerosis
Author Information
Author(s): Jank Larissa, Singh Saumitra S., Lee Judy, Dhukhwa Asmita, Siavoshi Fatemeh, Joshi Deepika, Minney Veronica, Gupta Kanak, Ghimire Sudeep, Deme Pragney, Schoeps Vinicius A., Soman Karthik, Ladakis Dimitrios, Smith Matthew, Borkowski Kamil, Newman John, Baranzini Sergio E., Waubant Emmanuelle L., Fitzgerald Kathryn C., Mangalam Ashutosh, Haughey Norman, Kornberg Michael, Chamling Xitiz, Calabresi Peter A., Bhargava Pavan
Primary Institution: Johns Hopkins University School of Medicine
Hypothesis
Can oral supplementation of indole lactate (ILA) restore gut microbial balance and improve multiple sclerosis outcomes?
Conclusion
Oral ILA supplementation reduces neuroinflammation and promotes remyelination in multiple sclerosis models.
Supporting Evidence
- ILA supplementation reduced peak and endpoint clinical scores in EAE mice.
- ILA treatment decreased immune cell infiltration and reduced spinal cord demyelination.
- Oral ILA supplementation increased the percentage of mature oligodendrocytes in the corpus callosum.
Takeaway
Giving a special gut metabolite called indole lactate to mice with multiple sclerosis helps them heal better and feel less sick.
Methodology
The study used two preclinical models of multiple sclerosis to assess the effects of ILA supplementation on neuroinflammation and remyelination.
Limitations
The high concentration of ILA required for effects in vitro may not reflect physiological conditions.
Statistical Information
P-Value
0.003
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website